Search Results - "Bach‐Rojecky, L."

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Role of central versus peripheral opioid system in antinociceptive and anti‐inflammatory effect of botulinum toxin type A in trigeminal region by Drinovac Vlah, V., Filipović, B., BachRojecky, L., Lacković, Z.

    Published in European journal of pain (01-03-2018)
    “…Background Although botulinum toxin type A (BT‐A) is approved for chronic migraine treatment, its site and mechanism of action are still elusive. Recently our…”
    Get full text
    Journal Article
  2. 2

    Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A by Matak, I, Bach-Rojecky, L, Filipović, B, Lacković, Z

    Published in Neuroscience (14-07-2011)
    “…Abstract Botulinum toxin A (BTX-A) is approved for treatment of different cholinergic hyperactivity disorders, and, recently, migraine headache. Although…”
    Get full text
    Journal Article
  3. 3

    A century of phage therapy: from novel discoveries about the past to the challenges of the today by Bach-Rojecky, L, Lacković, Z

    Published in Pharmazie (01-10-2021)
    “…The discovery of bacterial viruses able to kill bacteria, named bacteriophages (phages), more than a century ago, contributed to combating bacterial infections…”
    Get more information
    Journal Article
  4. 4

    Involvement of μ-opioid receptors in antinociceptive action of botulinum toxin type A by Drinovac, V., Bach-Rojecky, L., Matak, I., Lacković, Z.

    Published in Neuropharmacology (01-07-2013)
    “…Botulinum toxin A (BTX-A) is approved for treatment of chronic migraine and has been investigated in various other painful conditions. Recent evidence…”
    Get full text
    Journal Article
  5. 5

    Association of antinociceptive action of botulinum toxin type A with GABA-A receptor by Drinovac, V., Bach-Rojecky, L., Lacković, Z.

    Published in Journal of Neural Transmission (01-06-2014)
    “…The mechanism of botulinum toxin type A (BTX-A) antinociceptive action in the central nervous system is little known. The potential interaction between BTX-A…”
    Get full text
    Journal Article
  6. 6

    Antinociceptive action of botulinum toxin type A in carrageenan-induced mirror pain by Drinovac Vlah, V., Bach-Rojecky, L., Lacković, Z.

    Published in Journal of Neural Transmission (01-12-2016)
    “…“Mirror pain” or mirror-image pain (MP) is pain opposite to the side of injury. Mechanism and frequency in humans are not known. There is no consent on…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Botulinum toxin type A in experimental neuropathic pain by Bach-Rojecky, L, Relja, M, Lacković, Z

    Published in Journal of Neural Transmission (01-02-2005)
    “…A peripheral application of botulinum toxin type A (7 U/kg) has significantly reduced thermal and mechanical hypersensitivity in rats with the partial sciatic…”
    Get full text
    Journal Article
  9. 9

    Brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus by Tahirovic, I, Sofic, E, Sapcanin, A, Gavrankapetanovic, I, Bach-Rojecky, L, Salkovic-Petrisic, M, Lackovic, Z, Hoyer, S, Riederer, P

    “…It is believed that oxidative stress plays a central role in the pathogenesis of metabolic diseases like diabetes mellitus (DM) and its complications (like…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Central origin of the antinociceptive action of botulinum toxin type A by Bach-Rojecky, L, Lackovic, Z

    Published in Pharmacology, biochemistry and behavior (01-12-2009)
    “…Here we provide behavioural evidence for an axonal transport and the central origin of the antinociceptive effect of botulinum toxin type A (BTX-A). In rats we…”
    Get full text
    Journal Article
  12. 12

    Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: Bilateral effect after unilateral injection by Bach-Rojecky, Lidija, Šalković-Petrišić, Melita, Lacković, Zdravko

    Published in European journal of pharmacology (10-05-2010)
    “…We investigated antinociceptive activity of botulinum toxin type A (BTX-A) in a model of diabetic neuropathic pain in rats. Male Wistar rats were made diabetic…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Involvement of I14-opioid receptors in antinociceptive action of botulinum toxin type A by Drinovac, V, Bach-Rojecky, L, Matak, I, LackoviA, Z

    Published in Neuropharmacology (01-07-2013)
    “…Botulinum toxin A (BTX-A) is approved for treatment of chronic migraine and has been investigated in various other painful conditions. Recent evidence…”
    Get full text
    Journal Article
  15. 15

    Continuing war on pain: a personalized approach to the therapy with nonsteroidal anti-inflammatory drugs and opioids by Bach-Rojecky, Lidija, Vađunec, Dalia, Žunić, Katarina, Kurija, Jelena, Šipicki, Sara, Gregg, Ryan, Mikula, Ivan, Primorac, Dragan

    Published in Personalized medicine (01-03-2019)
    “…Successful pain management requires the delivery of analgesia with minimal risk of adverse drug reactions. Nonsteroidal anti-inflammatory drugs and opioids…”
    Get more information
    Journal Article
  16. 16

    Antinociceptive effect of botulinum toxin type a in rat model of carrageenan and capsaicin induced pain by Bach-Rojecky, Lidija, Lacković, Zdravko

    Published in Croatian medical journal (01-04-2005)
    “…To test antinociceptive properties of botulinum toxin type A (BTX-A) in rats with carrageenan- and capsaicin-induced pain and inflammation. Pain was provoked…”
    Get full text
    Journal Article
  17. 17